(Q37963769)

26 August 2017

title

Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention (English)

1 reference

26 August 2017

1 reference

1 reference

Joanne Lysaght

2

0 references

author name string

Mary-Clare Cathcart

series ordinal

1

1 reference

26 August 2017

Graham P Pidgeon

series ordinal

3

1 reference

26 August 2017

publication date

1 December 2011

1 reference

Cancer and Metastasis Reviews

26 August 2017

published in

1 reference

26 August 2017

volume

30

1 reference

26 August 2017

issue

3-4

1 reference

26 August 2017

page(s)

363-385

1 reference

https://scigraph.springernature.com/pub.10.1007/s10555-011-9324-x

26 August 2017

exact match

0 references

cites work

The role of cyclooxygenase and lipoxygenase in cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

The eicosanoids and their biochemical mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Targeting cyclooxygenase-2 in human neoplasia: rationale and promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Phase II, randomized, placebo-controlled trial of neoadjuvant celecoxib in men with clinically localized prostate cancer: evaluation of drug-specific biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Gemcitabine plus celecoxib in patients with advanced or metastatic pancreatic adenocarcinoma: results of a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

A COX-2 inhibitor combined with chemoradiation of locally advanced rectal cancer: a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Pilot randomized phase II study of celecoxib in oral premalignant lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Cytochrome P450-derived eicosanoids: the neglected pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Effect of eicosapentaenoic acid on E-type prostaglandin synthesis and EP4 receptor signaling in human colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

APC mutations occur early during colorectal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Genetic alterations during colorectal-tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

The colorectal adenoma-carcinoma sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

The relationship between cyclooxygenase-2 expression and characteristics of malignant transformation in human colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Evaluation of original dual thromboxane A2 modulators as antiangiogenic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Epoxygenase pathways of arachidonic acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Prostaglandins and leukotrienes: advances in eicosanoid biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

COX-2 in brain and spinal cord implications for therapeutic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

21 January 2018

Eicosanoids and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Prostaglandins and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Enhancement of colon carcinogenesis by prostaglandin E2 administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Genetic deletion of mPGES-1 accelerates intestinal tumorigenesis in APC(Min/+) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Prostaglandin E receptor subtype EP(1) deficiency inhibits colon cancer development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Prostanoid receptor expression in colorectal cancer related to tumor stage, differentiation and progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Hypermethylation of the prostacyclin synthase (PTGIS) promoter is a frequent event in colorectal cancer and associated with aneuploidy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Hematopoietic prostaglandin D synthase suppresses intestinal adenomas in ApcMin/+ mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Predisposition to colorectal cancer in rats with resolved colitis: role of cyclooxygenase-2-derived prostaglandin d2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Pro-inflammatory prostaglandins and progression of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Upregulation of thromboxane synthase in human colorectal carcinoma and the cancer cell proliferation by thromboxane A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Platelet activation in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Targeted genetic disruption of peroxisome proliferator-activated receptor-delta and colonic tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Crosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

15-Lipoxygenase-2 expression in benign and neoplastic lung: an immunohistochemical study and correlation with tumor grade and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

15-lipoxygenase 2 (15-LOX2) is a functional tumor suppressor that regulates human prostate epithelial cell differentiation, senescence, and growth (size).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Overexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Lipoxygenase-5 is overexpressed in prostate adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Levels of expression of lipoxygenases and cyclooxygenase-2 in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Prostaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Role of cAMP in the promotion of colorectal cancer cell growth by prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

The effects of the stromal cell-derived cyclooxygenase-2 metabolite prostaglandin E2 on the proliferation of colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

HEF1 is a crucial mediator of the proliferative effects of prostaglandin E(2) on colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Experimental cancer therapy using restoration of NAD+ -linked 15-hydroxyprostaglandin dehydrogenase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

The quest for new cysteinyl-leukotriene and lipoxin receptors: recent clues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

The modulating role of nuclear factor-kappaB in the action of alpha7-nicotinic acetylcholine receptor and cross-talk between 5-lipoxygenase and cyclooxygenase-2 in colon cancer growth induced by 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Peroxisome-proliferator-activated receptors and cancers: complex stories

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

15-LOX-1 inhibits p21 (Cip/WAF 1) expression by enhancing MEK-ERK 1/2 signaling in colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Apoptosis induced by activation of peroxisome-proliferator activated receptor-gamma is associated with Bcl-2 and NF-kappaB in human colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Histone deacetylase inhibitors and 15-deoxy-Delta12,14-prostaglandin J2 synergistically induce apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

PGE2 inhibits apoptosis in human adenocarcinoma Caco-2 cell line through Ras-PI3K association and cAMP-dependent kinase A activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

PI3-kinase/Wnt association mediates COX-2/PGE(2) pathway to inhibit apoptosis in early stages of colon carcinogenesis: chemoprevention by diclofenac

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

The proapoptotic BH3-only protein Bim is downregulated in a subset of colorectal cancers and is repressed by antiapoptotic COX-2/PGE(2) signalling in colorectal adenoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Cyclooxygenase inhibitors induce colon cancer cell apoptosis Via PPARdelta --> 14-3-3epsilon pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Clinicopathologic association of cyclooxygenase 1 and cyclooxygenase 2 expression in gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Tumorigenesis and the angiogenic switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated rece

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

A mechanistic study of colon cancer growth promoted by cigarette smoke extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Integrin signaling and cell growth control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Ligand binding regulates the directed movement of beta1 integrins on fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Prostaglandin E₂ regulates cellular migration via induction of vascular endothelial growth factor receptor-1 in HCA-7 human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Role of beta-arrestin 1 in the metastatic progression of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Effect of shear stress and a stable prostaglandin I2 analogue on adhesive interactions of colon cancer cells and endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Prostaglandin F(2alpha) stimulates motility and invasion in colorectal tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Effect of aspirin and NSAIDs on risk and survival from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Celecoxib for the prevention of sporadic colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Cyclooxygenase 2 modulates killing of cytotoxic T lymphocytes by colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Tumor-secreted PGE2 inhibits CCL5 production in activated macrophages through cAMP/PKA signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Mast cell 5-lipoxygenase activity promotes intestinal polyposis in APCDelta468 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Regulation of the eicosanoid pathway by tumour necrosis factor alpha and leukotriene D4 in intestinal epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Role of lipoxins and resolvins as anti-inflammatory and proresolving mediators in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Anti-inflammatory lipid mediators and insights into the resolution of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Lipoxin biosynthesis in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Depletion of regulatory T cells facilitates growth of established tumors: a mechanism involving the regulation of myeloid-derived suppressor cells by lipoxin A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-kappaB activation and the production of inflammatory cytokines in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Activation of the acute inflammatory response alters cytochrome P450 expression and eicosanoid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

The anti-inflammatory effects of soluble epoxide hydrolase inhibitors are independent of leukocyte recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

15-deoxy-Delta12,14-prostaglandin J2 inhibits the expression of microsomal prostaglandin E synthase type 2 in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Highly accumulated platelet vascular endothelial growth factor in coagulant thrombotic region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Mechanisms of cancer-induced thrombosis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Pharmacological evaluation of the novel thromboxane modulator BM-567 (II/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Effect of LY293111 in combination with gemcitabine in colonic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

5-Lipoxygenase inhibitors reduce PC-3 cell proliferation and initiate nonnecrotic cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Inhibition of 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Fat, fish, fish oil and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Dietary fish oil and pectin enhance colonocyte apoptosis in part through suppression of PPARdelta/PGE2 and elevation of PGE3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Inhibition of tumorigenesis in ApcMin/+ mice by a combination of (-)-epigallocatechin-3-gallate and fish oil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Effect of olive oil on early and late events of colon carcinogenesis in rats: modulation of arachidonic acid metabolism and local prostaglandin E(2) synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

A gamma-tocopherol-rich mixture of tocopherols inhibits colon inflammation and carcinogenesis in azoxymethane and dextran sulfate sodium-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Curcumin blocks prostaglandin E2 biosynthesis through direct inhibition of the microsomal prostaglandin E2 synthase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Molecular modeling of the non-covalent binding of the dietary tomato carotenoids lycopene and lycophyll, and selected oxidative metabolites with 5-lipoxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Assessing 12(S)-lipoxygenase inhibitory activity using colorectal cancer cells overexpressing the enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

The mechanisms of lipoxygenase inhibitor-induced apoptosis in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

Effects of green tea and high-fat diet on arachidonic acid metabolism and aberrant crypt foci formation in an azoxymethane-induced colon carcinogenesis mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

The MET oncogene drives a genetic programme linking cancer to haemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9324-X

10.1007/S10555-011-9324-X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference